{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-042893","form_type":"8-K","ticker":"ABT","cik":"0000001800","company_name":"ABBOTT LABORATORIES","filed_at":"2024-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.680330+00:00","generated_at":"2026-05-30T13:56:06.200674+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Abbott Q3 2024: GAAP EPS $0.94, adj. EPS $1.21; raises FY adj. EPS guidance midpoint","bullets":["Reported sales $10.6B (+4.9% reported, +8.2% organic ex-COVID tests); Medical Devices +13.3% organic.","GAAP diluted EPS $0.94; adjusted diluted EPS $1.21; FY 2024 adj. EPS guidance raised to $4.64-$4.70.","FreeStyle Libre CGM sales >$1.6B (+20.7% organic); new $7B share repurchase authorized; quarterly dividend $0.55.","Partnered with Medtronic to connect CGM with insulin devices; launched OTC Lingo CGM in U.S.; completed VOLT-AF trial enrollment.","Nutrition organic +3.4% (Adult +9.1%); Diagnostics organic ex-COVID +3.3% (Core Lab +4.5%); Established Pharma organic +7.0%."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-042893","json":"https://secwatch.observer/filing/0001628280-24-042893.json","markdown":"https://secwatch.observer/filing/0001628280-24-042893.md","text":"https://secwatch.observer/filing/0001628280-24-042893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800/000162828024042893/0001628280-24-042893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800/000162828024042893/abt-20241016.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:56:06.200674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}